This presentation will use case-based scenarios to illustrate different patterns of liver test abnormalities. The difference between cholestatic, hepatitis and infiltrative liver diseases and their characteristic liver test patterns will also be discussed.
IBS is a common gastrointestinal disorder characterized by chronic abdominal pain and an abnormal pattern of bowel movements (i.e., diarrhea, constipation or mixed diarrhea and constipation). This session will cover the diagnosis and management of this nebulous condition, including discussion of current guidelines and available and upcoming therapies for IBS.
This talk will outline the challenges associated with identifying patients with Barrett’s esophagus and the limitations of our current strategy of endoscopic surveillance biopsies. The risk of progression of nondysplastic Barrett’s esophagus, low-grade dysplasia, and high grade dysplasia to cancer will also be discussed. Endoscopic eradication techniques (EET) including endoscopic mucosal resection, radiofrequency ablation, and cryoablation will be described and the success rates and pros and cons of each type of EET will be reviewed.
This talk will discuss the appropriate use of PPIs, including FDA indications and other accepted uses based on guidelines and systematic reviews. There will also be a brief review of the literature regarding issues of PPI safety. While many retrospective studies have raised concerns about various health conditions associated with PPI use, the quality of these studies need to be accounted for when considering the potential benefit that can be derived from these medications, even with long-term use. Finally, the faculty will provide a summary of “best practices."
This presentation will use case-based scenarios to illustrate different patterns of liver test abnormalities. The faculty will discuss the difference between cholestatic versus hepatitis versus infiltrative liver diseases and their characteristic liver test patterns. You will learn about the workup of liver test abnormalities with subsequent supplemental serological testing, imaging, and in some cases, liver biopsy. After this session, you will know the difference between true “liver function tests,” tests of cholestasis, tests of inflammation, and tests of infiltration.
Join this lecture for an overview of the pathophysiology, evaluation, and management of patients with nonalcoholic fatty liver disease. The faculty will review current concepts, disease progression, and therapeutics. You will learn about surgical treatments and their impact in patients with nonalcoholic steatohepatitis and obesity as well as the risk for hepatocellular carcinoma.
This podcast is a case-based discussion around practical approaches to caring for patients with CIC and IBS-C. The conversation between a PCP and an expert will address the clinical presentation, differential diagnosis, workup, and treatment of CIC and IBS-C.
This podcast is a case-based discussion around diagnosis and management of chronic diarrhea in the outpatient setting. The conversation between a PCP and an expert will address clinical presentation, differential diagnosis, workup, and treatment of IBS-D.
This activity will provide an evidence-based approach to diagnosing irritable bowel syndrome (IBS) with minimal testing. Diagnostic tests that facilitate a positive diagnosis of IBS and effective approaches for educating patients will be highlighted. The speakers will spotlight diet changes and over-the-counter agents which are helpful first-line therapies. Evidence-based guidelines will identify the most effective and best tolerated prescription agents for IBS and chronic constipation patients.